Using Behavioral Economics to Support PrEP Adherence for HIV Prevention.

IF 3.7 2区医学 Q2 INFECTIOUS DISEASES

Current HIV/AIDS Reports Pub Date : 2022-10-01 Epub Date: 2022-08-31 DOI:10.1007/s11904-022-00624-y

Unmesha Roy Paladhi, David A Katz, Carey Farquhar, Harsha Thirumurthy

{"title":"Using Behavioral Economics to Support PrEP Adherence for HIV Prevention.","authors":"Unmesha Roy Paladhi, David A Katz, Carey Farquhar, Harsha Thirumurthy","doi":"10.1007/s11904-022-00624-y","DOIUrl":null,"url":null,"abstract":"Purpose of review: We explored different behavioral economics (BE) mechanisms through which pre-exposure prophylaxis (PrEP) initiation and adherence could be impacted and examined recent work using BE principles to further HIV prevention efforts. We also generated new intervention ideas based on existing HIV testing and ART adherence literature.Recent findings: There is limited work that uses BE principles to design interventions to increase PrEP initiation and adherence, mostly involving financial incentives. The recent works highlighted involve financial incentives and demonstrate that key populations are open to accepting monetary incentives to increase PrEP initiation and improve adherence. However, there are mixed results on the long-term impacts of using incentives to modify behavior. While there are a few ongoing studies that utilize BE principles to increase PrEP use, there is need to develop studies that test these concepts, to promote PrEP initiation and adherence. We suggest methods of exploring non-incentives-based ideas to increase PrEP use in key populations.","PeriodicalId":10930,"journal":{"name":"Current HIV/AIDS Reports","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428871/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current HIV/AIDS Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11904-022-00624-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 1

Abstract

Purpose of review: We explored different behavioral economics (BE) mechanisms through which pre-exposure prophylaxis (PrEP) initiation and adherence could be impacted and examined recent work using BE principles to further HIV prevention efforts. We also generated new intervention ideas based on existing HIV testing and ART adherence literature.

Recent findings: There is limited work that uses BE principles to design interventions to increase PrEP initiation and adherence, mostly involving financial incentives. The recent works highlighted involve financial incentives and demonstrate that key populations are open to accepting monetary incentives to increase PrEP initiation and improve adherence. However, there are mixed results on the long-term impacts of using incentives to modify behavior. While there are a few ongoing studies that utilize BE principles to increase PrEP use, there is need to develop studies that test these concepts, to promote PrEP initiation and adherence. We suggest methods of exploring non-incentives-based ideas to increase PrEP use in key populations.

查看原文本刊更多论文

使用行为经济学支持坚持PrEP预防艾滋病毒。

回顾目的:我们探讨了不同的行为经济学(BE)机制，通过这些机制可以影响暴露前预防(PrEP)的启动和坚持，并检查了最近使用BE原则进一步预防艾滋病毒的工作。我们还根据现有的艾滋病毒检测和抗逆转录病毒治疗依从性文献产生了新的干预想法。最近的发现:使用BE原则来设计干预措施以增加PrEP的启动和依从性的工作有限，主要涉及财政激励。最近的工作重点涉及财政激励，并表明关键人群愿意接受金钱激励，以增加PrEP的启动和改善依从性。然而，使用激励来改变行为的长期影响的结果好坏参半。虽然有一些正在进行的研究利用BE原则来增加PrEP的使用，但仍需要开展研究来测试这些概念，以促进PrEP的开始和坚持。我们建议探索以非激励为基础的方法，以增加关键人群的PrEP使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current HIV/AIDS Reports INFECTIOUS DISEASES-

CiteScore

8.10

自引率

2.20%

发文量

期刊介绍： This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of HIV/AIDS. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as antiretroviral therapies, behavioral aspects of management, and metabolic complications and comorbidity. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.